This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: The Innovative Contributions of Véronique Braud
Introduction
Véronique Braud is a notable inventor based in Grasse, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has implications for the treatment of autoimmune diseases and cancer.
Latest Patents
Braud's latest patents focus on LLT-1 antibodies with new functional properties. The present invention relates to monoclonal antibodies that are capable of specifically binding to lectin-like transcript 1 (LLT1). This includes polynucleotides encoding such antibodies and cells that express them. The antibodies developed by Braud have utility in treating autoimmune diseases and cancer, where LLT1- and CD161-expressing cells play a role in disease pathogenesis.
Career Highlights
Véronique Braud is affiliated with the Centre National de la Recherche Scientifique, a prominent research institution in France. His work has been instrumental in advancing the understanding of immune responses and therapeutic interventions.
Collaborations
Braud has collaborated with notable colleagues, including Petrus Johannes Louis Spee and Peter Andreas Nicolai Reumert Wagtmann. These collaborations have further enriched his research and innovation efforts.
Conclusion
Véronique Braud's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile